Accessibility Menu
Arrayit logo

Arrayit(OTC) ARYC

Market Cap$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0%
+0.00Today
Arrayit last closing stock price
MetricPriceDate
Last closeUSD 0.002026-06-26
Arrayit stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-05-18
1 month+0%USD 0.002026-05-18
3 month-99%USD 0.002026-03-10
Year to date+0%USD 0.002025-10-29
1 year+0%USD 0.002025-06-18
3 year-99%USD 0.002023-06-23
5 year-99.75%USD 0.002021-06-23
Since inception-100%USD 2.102008-02-22

Arrayit Financials at a Glance

Market Cap

$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.82M

Net Income (TTM)

-$7.57M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-17.05 (Low)

Price

$0.00

Volume

100,500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 20, 2015

ARYC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Arrayit

Arrayit Corporation is a global life sciences technology firm based in Sunnyvale, California. The company specializes in developing and commercializing advanced tools for genetic analysis and diagnostic applications.

Products and Services
  • Microarray instruments and components for genetic analysis
  • Custom microarray printing and analysis services
  • Diagnostic microarrays for early health condition identification
Growth Outlook
  • Innovative microarray technology supports diverse research applications
  • Expanding client base includes pharmaceutical and academic institutions
  • Potential for increased demand in genetic testing and diagnostics
Financial Highlights
  • Recent quarterly revenue of 615,151, showing growth potential
  • Gross profit margin of 60.32% indicates strong product demand
  • Operating cash flow trends suggest ongoing operational adjustments
Arrayit Corporation operates in the medical diagnostics and research industry, focusing on innovative solutions for genetic analysis. The company's product offerings include a range of microarray instruments and services, catering to various research and diagnostic needs. With a strong emphasis on technology, Arrayit is well-positioned to capitalize on the growing demand for genetic testing and diagnostics. The growth outlook for Arrayit is promising, driven by its innovative microarray technology that supports a wide array of research applications. The company has been expanding its client base, which includes pharmaceutical companies and academic institutions, indicating a robust market presence. As the demand for genetic testing continues to rise, Arrayit is poised to benefit from this trend. Financially, Arrayit reported a recent quarterly revenue of 615,151, reflecting its potential for growth. The gross profit margin of 60.32% highlights the strong demand for its products and services. Additionally, trends in operating cash flow suggest that the company is making necessary adjustments to enhance its operational efficiency. Overall, Arrayit Corporation presents an intriguing opportunity within the life sciences sector, with a focus on innovation and growth.
AI Generated • Jul 4, 2026

Industry

Life Sciences Tools and Services

Headquarters

Sunnyvale, CA 94085, US

ARYC Financials

Key Financial Metrics (TTM)

Gross Margin

58.83%

Operating Margin

-82.76%

Net Income Margin

-75.75%

Return on Equity

54.80%

Return on Capital

N/A

Return on Assets

-331.43%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

793.48M

Volume

100.50K

Avg. Volume

1.73K

Financials (TTM)

Gross Profit

$1.39M

Operating Income

-$6.73M

EBITDA

-$6.60M

Operating Cash Flow

-$686.71K

Capital Expenditure

-$10.45K

Free Cash Flow

-$697.16K

Cash & ST Invst.

$0.00

Total Debt

$924.50K

Arrayit Performance Analysis

Arrayit sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42014-12-3171.5%
Q12015-03-31-6.8%
Q22015-06-30-27.1%
Q32015-09-307.3%
Arrayit sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42014-12-31-439026.2%
Q12015-03-3199.9%
Q22015-06-3092.0%
Q32015-09-30-266.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2015YOY CHG

Revenue

$615.15K

+24.9%

Gross Profit

$371.05K

+77.5%

Gross Margin

60.32%

N/A

Market Cap

$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$114.29

N/A

Employees

7

N/A

Net Income

-$3.16M

-672.9%

EBITDA

-$3.19M

-771.0%

Quarterly Fundamentals

Name
Q3 2015YOY CHG

Total Cash

$0.00

-100.0%

Total Debt

$924.50K

+8.0%

Accounts Receivable

$209.66K

+24.6%

Inventory

$545.73K

-4.9%

Long Term Debt

$0.00

N/A

Short Term Debt

$924.50K

+8.0%

Return on Assets

-3.31%

N/A

Return on Invested Capital

55.76%

N/A

Free Cash Flow

$6.41K

+106.0%

Operating Cash Flow

$10.73K

+110.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BRAXFBraxia Scientific Corp.
$0.00+0.00%
TRCNFTransnational Cannabis Ltd.
$0.00+0.00%
MOBOMobile Lads Corp.
$0.00+0.00%
GREHGreen Rain Energy Holdings Inc.
$0.01-1.45%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.25-0.09%
INTCIntel
$81.88-0.05%
NVDANvidia
$190.01-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About ARYC

What is the current price of Arrayit?

Arrayit is trading at $0.00 per share.

What is the 52-week range for Arrayit?

Over the past 52 weeks, Arrayit has traded between $0.00 and $0.00.

How much debt does Arrayit have?

Arrayit total debt is unavailable.

How much cash does Arrayit have on hand?

Arrayit does not have cash on hand data available.

What is Arrayit’s dividend yield?

Arrayit does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.